Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ismael Sanchez-Pareja
Observed names:
I. Sanchez-Pareja,
Ismael Sanchez‐Pareja,
Ismael Sánchez-Pareja
Institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
University of Córdoba
Observed institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
University of Córdoba
ORCID:
0000-0002-9766-1942
Observed ORCID:
0000-0002-9766-1942
OpenAlex ID:
A5023191173
Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs
2024
·
Laura Muñoz-Barrera
, Carlos Perez-Sanchez
, et al.
·
Biomedicine & Pharmacotherapy
·
10
PDF
Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features
2023
·
Ch Lopez-Pedrera
, A.M. Patiño-Trives
, et al.
·
Journal of Autoimmunity
·
7
Metabolomic and machine learning enhances patient diagnosis and stratification in systemic autoimmune diseases
2025
·
Carlos Perez-Sanchez
, Antonio Perez-Campoamor
, et al.
·
Computers in Biology and Medicine
·
5
Identification of a novel transcriptome signature for predicting the response to anti-TNF-α treatment in patients with rheumatoid arthritis
2025
·
Lucia Santiago-Lamelas
, Patricia Castro-Santos
, et al.
·
Annals of the Rheumatic Diseases
·
3
PDF
Pos0130 the Use of High-throughput Technologies for Molecular Profiling in Rheumatoid Arthritis Enables the Identification of Patient Subgroups With Distinctive Disease Activity and Therapeutic Response
2024
·
C. Lopez-Pedrera
, I. Sanchez-Pareja
, et al.
·
Annals of the Rheumatic Diseases
·
3
Pos0488 Identification of Novel Disease Biomarkers in Systemic Sclerosis Through High-throughput Proteomics
2022
·
R. Ortega Castro
, F.U. Pilar
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
Pos1038 Nad+ Boosters as a Novel Anti-inflammatory Tool in Rheumatoid Arthritis Patients
2023
·
C. Perez-Sanchez
, A. Escudero Contreras
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Pos1408 Integrated Metabolomics and Proteomics Network Analysis in Systemic Lupus Erythematosus Patients Highlights Metabolic and Immunity Pathways Associated With Distinctive Clinical Profiles
2023
·
T. Cerdó
, C. Perez-Sanchez
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Ex vivo JAK and TNF inhibitor–modulated immune signatures guide first-line therapy selection in rheumatoid arthritis
2026
·
Sagrario Corrales
, Carlos Pérez-Sánchez
, et al.
·
Biomarker Research
PDF
Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications
2026
·
Tomás Cerdó
, Laurel Woodridge
, et al.
·
Arthritis & Rheumatology
POS1139 Unravelling transcriptomic landscapes in rheumatoid arthritis and systemic lupus erythematosus: shared and unique molecular signatures related to relevant clinical features
2025
·
T. Cerdó
, I. Sanchez-Pareja
, et al.
·
Annals of the Rheumatic Diseases
Abs0033 Synovial Protein Signatures as Predictive Serum Biomarkers of Inflammation, Disease Activity, and Treatment Response in Early Rheumatoid Arthritis
2025
·
S. Corrales-Díaz Flores
, C. Aranda-Valera
, et al.
·
Annals of the Rheumatic Diseases
Abs0045 Sex and Age-related Inflammatory Profiles in Rheumatoid Arthritis: Impact on Disease Activity and Treatment Response.
2025
·
C. Lopez-Pedrera
, A. García-Alonso
, et al.
·
Annals of the Rheumatic Diseases
Abs0110 Integrative Omics Reveals Molecular Signatures Distinguishing Early From Established Rheumatoid Arthritis and Predicting Clinical Response
2025
·
I. Sanchez-Pareja
, C. Perez-Sanchez
, et al.
·
Annals of the Rheumatic Diseases
Op0237 Integrative Metabolomic and Inflammatory Profiling in Rheumatoid Arthritis: Disease Activity, Therapeutic Modulation, and Underlying Hepatic Mechanisms
2025
·
L. Muñoz-Barrera
, C. Perez-Sanchez
, et al.
·
Annals of the Rheumatic Diseases
POS0712 CLINICAL IMPACT AND MOLECULAR CHANGES IN THE CARDIOVASCULAR PROFILE OF BARICITINIB ON BIOLOGIC-NAÏVE RHEUMATOID ARTHRITIS PATIENTS: COMPARATIVE ANALYSIS WITH TNF INHIBITORS AND cDMARDs
2025
·
L. Muñoz-Barrera
, C. Perez-Sanchez
, et al.
·
Annals of the Rheumatic Diseases
Pos0065 an Immune-molecular Signature Modulated by Jak Inhibitors Ex Vivo Predicts in Vivo Therapy Response and Exhibits Specificity Compared to Anti-tnf Treatments in Rheumatoid Arthritis
2025
·
S. Corrales-Díaz Flores
, C. Perez-Sanchez
, et al.
·
Annals of the Rheumatic Diseases
Pos1319 Personalized Lipidomic and Proteomic Profiles Identify Aps Patients With Distinctive Atherothrombotic Risk
2024
·
B. Vellón-García
, C. Perez-Sanchez
, et al.
·
Annals of the Rheumatic Diseases
Pos1401 Integration of Proteomic and Metabolomic Analyses for Stratifying Systemic Lupus Erythematosus Patients: Unveiling Signatures Associated With Cardiovascular Risk and Renal Complications
2024
·
C. Lopez-Pedrera
, T. Cerdó
, et al.
·
Annals of the Rheumatic Diseases
Pos0154 Early and Established Rheumatoid Arthritis Patients Exhibit Distinctive Circulating Inflammatory Signatures Associated With Relevant Biologic Pathways
2024
·
C. Perez-Sanchez
, B. Vellón-García
, et al.
·
Annals of the Rheumatic Diseases
Ab0752 Contribution of Secreted Synovial Tissue Proteins to Serum Inflammatory Profiles, Clinical Features, and Therapeutic Responses in Rheumatoid Arthritis Patients
2024
·
C. Lopez-Pedrera
, C. Perez-Sanchez
, et al.
·
Annals of the Rheumatic Diseases
Pos1205 Cellular and Molecular Mechanisms Underlying the Effects of Biologic and Targeted Synthetic Dmards in Rheumatoid Arthritis Immune Cells: Ex Vivo Studies
2024
·
C. Lopez-Pedrera
, S. Corrales-Díaz Flores
, et al.
·
Annals of the Rheumatic Diseases
Pos0725 Uncovering Novel Common and Distinctive Gene Signatures in Rheumatoid Arthritis and Systemic Lupus Erythematosus Through Integrative Transcriptomic Analysis
2024
·
C. Lopez-Pedrera
, I. Sanchez-Pareja
, et al.
·
Annals of the Rheumatic Diseases
Pos0623 Integrated Serum Proteomic and Metabolomic Profiles in Systemic Sclerosis Patients Characterize New Biomarkers Associated to Relevant Pathological Features
2023
·
I. Sanchez-Pareja
, R. Ortega Castro
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos0293 Metabolomic in Antiphospholipid Syndrome Stratified Patients According to Their Thrombotic Risk
2023
·
C. Lopez-Pedrera
, M.A. Aguirre
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
28
Citation count:
32
H-index:
3
I10-index:
1
Year
Topic
Type